204 related articles for article (PubMed ID: 32196588)
41. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
42. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
[TBL] [Abstract][Full Text] [Related]
43. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
[TBL] [Abstract][Full Text] [Related]
44. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.
Wei W; Liu Y; Lu Y; Yang B; Tang L
J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543
[TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNA LINC01559 promotes pancreatic cancer progression by acting as a competing endogenous RNA of miR-1343-3p to upregulate RAF1 expression.
Chen X; Wang J; Xie F; Mou T; Zhong P; Hua H; Liu P; Yang Q
Aging (Albany NY); 2020 Jul; 12(14):14452-14466. PubMed ID: 32678071
[TBL] [Abstract][Full Text] [Related]
46. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
47. p21-activated kinase 2 binds to transcription factor SOX2 and up-regulates DEK to promote the progression of lung squamous cell carcinoma.
Xie S; Wan X; Chen S; Hu Y; Liu X
Lab Invest; 2022 Oct; 102(10):1109-1120. PubMed ID: 35821094
[TBL] [Abstract][Full Text] [Related]
48. LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis.
Lu T; Wei GH; Wang J; Shen J
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10462-10471. PubMed ID: 33155202
[TBL] [Abstract][Full Text] [Related]
49. miR-181-5p attenuates neutrophilic inflammation in asthma by targeting DEK.
Song Y; Wang Z; Jiang J; Piao Y; Bai Q; Piao Q; Li L; Xu C; Liu H; Piao H; Li L; Yan G
Int Immunopharmacol; 2022 Nov; 112():109243. PubMed ID: 36115279
[TBL] [Abstract][Full Text] [Related]
50. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
51. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
[TBL] [Abstract][Full Text] [Related]
52. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a.
Zhang X; Gao F; Zhou L; Wang H; Shi G; Tan X
Oncol Res; 2017 Nov; 25(9):1529-1541. PubMed ID: 28315290
[TBL] [Abstract][Full Text] [Related]
53. The interaction of long non-coding RNA MIAT and miR-133 play a role in the proliferation and metastasis of pancreatic carcinoma.
Li TF; Liu J; Fu SJ
Biomed Pharmacother; 2018 Aug; 104():145-150. PubMed ID: 29772434
[TBL] [Abstract][Full Text] [Related]
54. Long non-coding RNA MCM3AP-AS1 promotes growth and migration through modulating FOXK1 by sponging miR-138-5p in pancreatic cancer.
Yang M; Sun S; Guo Y; Qin J; Liu G
Mol Med; 2019 Dec; 25(1):55. PubMed ID: 31830901
[TBL] [Abstract][Full Text] [Related]
55. Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene.
Zhai H; Zhang X; Sun X; Zhang D; Ma S
Dig Dis Sci; 2020 Apr; 65(4):1042-1052. PubMed ID: 31562613
[TBL] [Abstract][Full Text] [Related]
56. Long non-coding RNA LINC01963 inhibits progression of pancreatic carcinoma by targeting miR-641/TMEFF2.
Li K; Han H; Gu W; Cao C; Zheng P
Biomed Pharmacother; 2020 Sep; 129():110346. PubMed ID: 32559621
[TBL] [Abstract][Full Text] [Related]
57. Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
Oncotarget; 2016 May; 7(18):26844-55. PubMed ID: 27057626
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
59. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
60. [Construction of RNA interference (RNAi) lentiviral expression vector of DEK gene and its effect on the biological behavior of liver cancer cells].
Li SH; Hou Y; Chen Z; Wu WR; Wu CX; Sun H
Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):868-875. PubMed ID: 33105933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]